Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

2.

Factors that influence the prescription of antipsychotics for patients with schizophrenia in china.

Si TM, Shu L, Li KQ, Liu XH, Mei QY, Wang GH, Bai PS, Ji LP, Chen XS, Ma C, Shi JG, Zhang HY, Ma H, Yu X.

Clin Psychopharmacol Neurosci. 2011 Dec;9(3):122-8. doi: 10.9758/cpn.2011.9.3.122. Epub 2011 Dec 31.

4.

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia.

Ren XS, Herz L, Qian S, Smith E, Kazis LE.

Neuropsychiatr Dis Treat. 2009;5:491-8. Epub 2009 Oct 12.

5.

Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Masand PS, Roca M, Turner MS, Kane JM.

Prim Care Companion J Clin Psychiatry. 2009;11(4):147-54. doi: 10.4088/PCC.08r00612.

7.

Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia.

dosReis S, Johnson E, Steinwachs D, Rohde C, Skinner EA, Fahey M, Lehman AF.

Schizophr Res. 2008 Apr;101(1-3):304-11. doi: 10.1016/j.schres.2007.12.475. Epub 2008 Feb 5.

8.

Open access to innovative drugs: treatment substitutions or treatment expansion?

McCombs JS, Mulani P, Gibson PJ.

Health Care Financ Rev. 2004 Spring;25(3):35-53.

9.

Use of conventional antipsychotics and the cost of treating schizophrenia.

Lyu RR, McCombs JS, Johnstone BM, Muse DN.

Health Care Financ Rev. 2001 Winter;23(2):83-99.

Supplemental Content

Support Center